Article
Innovative treatment programs against cancer. I. Ras oncoprotein as a molecular target.
Biochemical pharmacology - 1 Dec 1998
Waddick K G, Uckun F M
Abstract excerpt
Modulation of Ras function may provide a novel means by which cancer cells with oncogenic mutations can be sensitized to chemotherapeutic or radiotherapeutic regimens. Moreover, cancer cells without ras oncogene mutations can also be eliminated by compounds that interfere with the mevalonate pathway, which is more fundamental to mitogenesis because it allows the synthesis of sterol and nonsterol lipids and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
